Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kaimosin-Forte
- Development stage
- Phase 4
- Lead developer
- Kaiser Medical Clinic
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Administration
- Oral
01
Overview
Kaimosin-Forte is an oral proteolytic enzyme preparation manufactured by Kaiser Pharmaceutical, a branded generic pharmaceutical company based in India. The formulation contains a combination of the enzymes trypsin and chymotrypsin at a strength of 100,000 Armour Units (AU). These enzymes act as anti-inflammatory and anti-edema agents by catalyzing the hydrolysis of proteins at the site of injury or inflammation. This proteolytic action helps in the resolution of exudates, reduces swelling, improves local blood circulation, and facilitates the healing of necrotic tissue. It is primarily indicated for the management of edema and inflammation associated with accidental or surgical trauma, as well as other inflammatory conditions.
- Brand names
- Kaimosin-Forte
- Other names
- Trypsin-Chymotrypsin
02
Targets
CTRC (Chymotrypsin C)PRSS1 (Trypsin family)
Beyond the preview
Go deeper on Kaimosin-Forte.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kaimosin-Forte.